Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.

Yamada H, Hosokawa M, Itoh K, Takenouchi T, Kinoshita Y, Kikkawa T, Sakashita K, Uemura S, Nishida Y, Kusumi T, Sasaki S.

Surg Today. 2014 Jul;44(7):1258-65.

PMID:
24077997
2.

Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.

Manabe O, Hattori N, Hirata K, Itoh K, Hosokawa M, Takahashi H, Oyama-Manabe N, Tamaki N.

J Nucl Med. 2013 May;54(5):670-6. doi: 10.2967/jnumed.112.110304. Epub 2013 Mar 20.

3.
4.

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.

Clin Nucl Med. 2000 Nov;25(11):882-7.

PMID:
11079584
5.

The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.

Lu P, Sun Y, Sun Y, Yu L.

Lung Cancer. 2014 Jul;85(1):53-8. doi: 10.1016/j.lungcan.2014.04.004. Epub 2014 Apr 18.

PMID:
24792334
6.

[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].

Yuan SH, Yu JM, Yu YH, Fu Z, Guo HB, Liu TH, Yang XH, Yang GR, Li WW.

Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):221-4. Chinese.

PMID:
17649642
7.

Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.

Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.

Cancer. 2002 Feb 15;94(4):921-8.

8.

Evaluation of esophageal cancer by positron emission tomography.

Himeno S, Yasuda S, Shimada H, Tajima T, Makuuchi H.

Jpn J Clin Oncol. 2002 Sep;32(9):340-6.

9.

[Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].

Pifarré-Montaner P, Fernández-León A, de Juan R, del Ama-Salvador ME, Galán M, Gámez-Cenzano C, Sans M.

Rev Esp Med Nucl. 2009 May-Jun;28(3):101-5. Spanish.

10.

The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.

Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Hatazawa J, Doki Y.

Ann Surg Oncol. 2012 Feb;19(2):652-60. doi: 10.1245/s10434-011-1928-4. Epub 2011 Jul 19.

PMID:
21769466
11.

The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.

Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.

Cancer. 2005 Jan 1;103(1):148-56.

12.

Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.

Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, Kim BT.

J Nucl Med. 2000 May;41(5):808-15.

13.
14.

Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.

Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, Takiguchi S, Higuchi I, Hatazawa J, Monden M.

Surgery. 2008 Nov;144(5):793-802. doi: 10.1016/j.surg.2008.06.026. Epub 2008 Sep 10.

PMID:
19081023
15.

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.

J Clin Oncol. 2000 Sep 15;18(18):3202-10.

PMID:
10986052
16.

Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.

Ela Bella AJ, Zhang YR, Fan W, Luo KJ, Rong TH, Lin P, Yang H, Fu JH.

Chin J Cancer. 2014 Apr;33(4):211-7. doi: 10.5732/cjc.013.10039. Epub 2014 Feb 14.

17.

Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.

Shimizu S, Hosokawa M, Itoh K, Fujita M, Takahashi H, Shirato H.

Int J Clin Oncol. 2009 Oct;14(5):421-5. doi: 10.1007/s10147-009-0893-4. Epub 2009 Oct 25.

PMID:
19856050
18.

Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.

Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, Shiozaki H.

Ann Nucl Med. 2009 Jan;23(1):73-80. doi: 10.1007/s12149-008-0209-1. Epub 2009 Feb 11.

PMID:
19205841
19.

Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.

Karashima R, Watanabe M, Imamura Y, Ida S, Baba Y, Iwagami S, Miyamoto Y, Sakamoto Y, Yoshida N, Baba H.

Surg Today. 2015 Apr;45(4):471-7. doi: 10.1007/s00595-014-0965-6. Epub 2014 Jun 28. Erratum in: Surg Today. 2015 Apr;45(4):478. Dosage error in article text.

PMID:
24969050
20.

A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.

Yu W, Fu XL, Zhang YJ, Xiang JQ, Shen L, Chang JY.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e759-65. doi: 10.1016/j.ijrobp.2010.10.065. Epub 2011 Apr 4.

PMID:
21470788
Items per page

Supplemental Content

Write to the Help Desk